RxDoctor Payments DataLook up a doctor →

Mathew Tilson

Nurse Practitioner · Milwaukee, WINPI 1467763813

Payments from drug & device makers

$20,762in general payments, 2019–2025

Across 976 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$5K
  • AbbVie$4K
  • AstraZeneca$1K
  • Pfizer$990
  • Novo Nordisk$839
  • Takeda Pharmaceuticals U.S.A., Inc.$803
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead69$4,594
AbbVie260$3,626
AstraZeneca(2 entities)71$1,411
Pfizer54$990
Novo Nordisk53$839
Takeda Pharmaceuticals U.S.A., Inc.38$803
Lilly USA, LLC50$780
Johnson & Johnson45$771
Bayer26$528
Boehringer Ingelheim27$485
Vanda Pharmaceuticals Inc.23$482
Daiichi Sankyo Inc.16$349
Orexo US, Inc.17$333
GSK15$313
Novartis14$268
Exact Sciences10$212
Axsome Therapeutics, Inc.8$193
Electromed, Inc.10$186
Lundbeck LLC8$186
Amgen8$179
Dexcom, Inc.9$178
Teva Pharmaceuticals USA, Inc.4$171
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$161
Ardelyx, Inc.6$147
Harmony Biosciences LLC8$143
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$133
Idorsia Pharmaceuticals US Inc6$127
Mylan Specialty L.p.7$123
Ironwood Pharmaceuticals, Inc7$118
Indivior Inc.4$109
Neurocrine Biosciences, Inc.5$107
Mallinckrodt Hospital Products Inc.5$98
Sanofi-aventis U.S. LLC4$91
Nestle Healthcare Nutrition Inc.5$91
Viatris Specialty LLC4$87
Almatica Pharma LLC3$77
Myriad Women's Health, Inc.2$76
Alnylam Pharmaceuticals Inc.3$76
Medtronic1$67
Sumitomo Pharma America, Inc.3$66
E.r. Squibb & Sons, L.L.C.2$63
Biohaven Pharmaceutical Holding Company Ltd.3$57
Amneal Pharmaceuticals LLC3$56
Biohaven Pharmaceuticals, Inc.3$53
Merck4$53
Sunovion Pharmaceuticals Inc.6$52
Inspire Medical Systems, Inc.1$49
Xeris Pharmaceuticals, Inc.2$49
OPKO Pharmaceuticals, LLC2$47
Aimmune Therapeutics, Inc.2$43
Astellas Pharma US Inc2$43
Sanofi2$42
Esperion Therapeutics, Inc.2$38
Kowa Pharmaceuticals America, Inc.2$38
Liquidia Technologies, Inc.1$32
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)2$31
IBSA Pharma Inc.2$31
USWM, LLC2$30
Actelion Pharmaceuticals US, Inc.1$24
Grifols USA, LLC1$23

How this compares

$20,762 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin →

Medicare billing

Part B allowed, 2024
$52,505
Medicare patients
222
Services billed
775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Milwaukee

See the full list for Wisconsin →

Where these figures come from

Is this you, or does something look wrong? →